Researchers at the Bellvitge Biomedical Research Institute (IDIBELL), with the participation of collaborators from the Baylor College of Medicine (Houston) and the University Institute of Oncology of Asturias (IUOPA), publish ...
Jun 18, 2019
0
0
The use of molecular biomarkers in minimally invasive sampling opens a promising perspective for the early detection of endometrial cancer. This is the conclusion reached by the members of Screenwide research group, formed ...
Jun 17, 2019
0
1
Cognitive impairment associated with cancer, also known as "chemobrain," has gained recognition as a complication of the disease and its treatment, as it can negatively affect the daily lives of cancer patients and survivors.
Apr 23, 2019
0
8
Prostate cancer can grow slowly and pose little threat to patients, or it can metastasize quickly, causing severe pain and death. But as of now, it's nearly impossible to determine which type of cancer a patient has during ...
Apr 2, 2019
0
12
There is insufficient evidence to underpin the use of tumour markers to detect the recurrence of testicular cancer in patients who have undergone surgery for an initial tumour, finds research from Oxford University published ...
Mar 27, 2019
0
6
According to the latest GLOBOCAN cancer database, New Zealand's breast cancer incidence rate is among the highest in the world. It affects one in nine women in their lifetime and accounts for almost half of all cancers for ...
Mar 1, 2019
0
24
A multi-center study led by researchers at The University of Texas MD Anderson Cancer Center revealed that a liquid biopsy test called Guardant360, is comparable to standard tissue biopsies in detection of guideline recommended ...
Feb 27, 2019
1
3
As new technology allows researchers to plunge deeper into the genome and exome, a new class of RNA called circular RNA may play an intriguing role.
Feb 7, 2019
0
46
Over 90 percent of malign tumours in the head and neck are originated from carcinomas of squamous cells that appear in superficial areas of the oral cavity. Their detection with salivary biomarkers can contribute to early ...
Nov 15, 2018
0
2
The most aggressive type of prostate cancer, castration-resistant prostate cancer, can be treated via two therapies: taxanes or hormone treatment. Until recently, there were no comparative studies between the two, and the ...
Nov 14, 2018
0
6
